COX-2 Inhibitor Found To Help Prevent Gastric Cancer

Published: 2004-12-07 06:59:00

Updated: 2004-12-07 06:59:00

The Korea Food and Drug Administration (KFDA) announced December 3rd on its discovery of additional efficacy of COX-2 (cyclooxygenase-2) inhibitor, which is a type of non-steroidal anti-inflammatory drugs (NSAIDs) for treatment of arthritis, in prevention of gastric cancer of Helicobacter pylori ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK